This page converts five selected ideas into investigations that could produce a numerical answer without a laboratory. It is a test plan, not a result. The distinction matters on this site: a plan has no evidence level, and none is assigned.
Each investigation is required to produce four things, and to fail visibly if it cannot:
| Required output | Meaning |
|---|---|
| Baseline | What established science already predicts, computed first, so that any disagreement is located rather than assumed. |
| New prediction | The specific quantity where the hypothesis differs from the baseline, with a sign and a size. |
| Falsification | A measurement or held-out comparison that can show the hypothesis wrong. |
| Reproducibility | Code, data provenance, fixed seeds, figures, and a single verdict. |
Negative results are to be published with the same weight as supportive ones. Four of the five tests below are designed so that "the established model already explains this" is the most likely outcome; that outcome is the point.
| Label | Meaning |
|---|---|
| planned | A test design exists with a stated decision rule. No computation has been run. |
| baseline reproduced | The established model has been implemented and matches a published value. |
| departure found | The hypothesis differs from the baseline by more than the stated uncertainty. |
| not supported | The departure is absent, or reverses under a stated control. |
| inconclusive | Required data are missing or not matched, so no verdict is possible. |
All five are currently planned. That label is the honest one and it should not be read as progress.
| # | Hypothesis | Domain | Online feasibility | Principal risk |
|---|---|---|---|---|
| 1 | Pressure-induced gas-membrane selectivity reversal | Materials · transport | High | A reversal may only appear in models that are not physically constrained enough to be believed. |
| 2 | Cross-system response-time mismatch law | Applied maths · control | Very high | First-order lag is textbook; a "law" may be the standard Bode response renamed. |
| 3 | Enzyme substrate-competition switching | Biochemistry · kinetics | High | The relative-rate crossover is already fixed by established competitive kinetics. |
| 4 | Fog collection versus surface geometry | Fluid mechanics | Moderate | Simulation cannot establish collection efficiency; only a ranked hypothesis set. |
| 5 | Cellular expression variability and drug response | Biology · public data | Moderate, data-dependent | Matched single-cell plus drug-response data may not exist publicly. |
The order is a judgement about what can fail fastest and cheapest, not about which idea is best.
Original claim (preserved): a membrane combining more than one transport mechanism can show a pressure-dependent crossover in gas selectivity, with a reproducible reversal for certain gas pairs and pore geometries.
Refined, falsifiable form: for a membrane in which Knudsen, solution–diffusion and adsorption-assisted (surface) transport act in parallel, the permeance ratio αij(P) for a stated gas pair is non-monotonic in pressure and crosses unity at a pressure P* that moves predictably with pore radius, temperature and adsorption affinity. The test is whether any such crossing survives when the transport model is constrained by independently measured isotherms rather than fitted.
Each mechanism alone is monotonic: Knudsen selectivity is pressure-independent; solution–diffusion permeance is pressure-independent above the linear regime; a Langmuir surface term saturates. A crossover therefore requires the mixture — and specifically requires that the saturating channel dominate at low pressure while the non-saturating channel dominates at high pressure. This is arithmetic, not a discovery, and the baseline computation should show it explicitly.
Advance only if a crossing survives step 5 (constrained isotherms), persists under ±20% parameter perturbation, and is not contradicted by an existing mixed-gas measurement. The hypothesis dies if every crossing vanishes once adsorption parameters are constrained — which is the most likely outcome and would itself be a useful negative result: "the reversal is an artefact of unconstrained fitting."
Deliverable: a pressure–temperature map with the regions where α crosses unity, flagged by whether the underlying parameters came from measurement or from a scan.
Original claim (preserved): a dimensionless ratio between intrinsic response time and external forcing timescale helps predict loss of tracking performance across different dynamical systems; any universal threshold must be established, not assumed.
Refined, falsifiable form: define R = τresponse/Tforcing. For linear systems the tracking error is a function of R alone (the standard first-order Bode response), so the only testable content is whether a shared threshold survives across systems of different order, nonlinearity and noise. The claim is that a single curve predicts held-out systems; the baseline says the curve is order-dependent and therefore not shared.
For a first-order lag driven sinusoidally, |error|/|input| = 1/√(1+(ωτ)²) — a function of R only. For second order, a damping ratio enters and the collapse fails. The baseline computation must show the collapse failing for order ≥ 2 before any new law is proposed. If it does not fail, the "law" is the standard response function.
Decision: advance only if a single normalised curve predicts held-out model families better than the order-specific baseline. Dies if the collapse requires a per-order parameter, because then R carries no cross-system information.
Original claim (preserved): competition between primary and secondary substrates creates a predictable transition in relative enzyme activity, characterisable by dimensionless concentration ratios.
Refined, falsifiable form: for mutually exclusive substrates, the relative rate is already determined by established kinetics:
v_i = E_T k_cat,i (S_i/K_m,i) / (1 + Σ_j S_j/K_m,j)
So the crossover in v₂/v₁ as a function of S₂/S₁ is fixed by the ratio of specificity constants, and is not a new prediction. The only testable content is a systematic departure from this form — for example from allosteric competition, substrate inhibition, or a second binding site.
Decision: advance only if an extension beats the conventional model on held-out enzymes. Dies if the conventional model already predicts within the stated uncertainty — in which case the hypothesis is a rediscovery and should be recorded as such rather than deleted.
Original claim (preserved): the ratio of feature spacing to incident droplet diameter predicts collection performance, with an optimum that depends on wettability, airflow and droplet-size distribution.
Refined, falsifiable form: in a droplet-interception-and-drainage model, collection per unit area is non-monotonic in the spacing ratio s/d, with an optimum whose position moves with contact angle and wind speed. The claim is a shape prediction (a maximum exists, and it moves), not a performance number.
Decision: advance if the optimum is robust across a factor-two change in droplet distribution. Limit, stated up front: this can only rank designs. It cannot establish real-world collection efficiency, and no such claim will be made.
Original claim (preserved): after controlling for mean expression, cell identity and technical noise, biological expression variability carries additional information about drug sensitivity.
Refined, falsifiable form: adding noise-adjusted dispersion (not raw variance) to a model that already contains mean expression, lineage and technical covariates improves held-out prediction of drug response across cell lines. The critical control is that variability is measured within comparable populations; variance across unrelated lines is a different quantity and does not test the claim.
The claim needs single-cell expression matched to drug response. Bulk expression plus drug response exists (DepMap, Sanger), but bulk data contain no within-population variability. If matched single-cell plus response data cannot be located, the correct outcome is inconclusive, not a substitution of bulk variance for single-cell variance.
Decision: advance only if the dispersion term improves held-out accuracy consistently and the interval excludes zero. Dies if the improvement vanishes under line-level holdout, which is the standard signature of leakage.
| Test | Feasibility | First-pass effort | Why this position |
|---|---|---|---|
| Membrane reversal | High | 1–2 days | Three mechanisms with known limiting cases; the constrained-isotherm control can kill it quickly. |
| Response-time mismatch | Very high | 1 day | Pure simulation; the order-dependence baseline is decisive and cheap. |
| Enzyme switching | High | 2–4 days | Depends on how many enzymes have both constants and a two-substrate scan. |
| Fog geometry | Moderate | 2–4 days | Model-building dominates; result can only rank designs. |
| Cellular variability | Moderate, data-dependent | 3–7 days | Blocked until matched data are confirmed to exist. |
Effort assumes an AI coding agent and ordinary Python libraries, with no physical experiment.
| Test | What is already established | What could be new, if anything |
|---|---|---|
| Membrane | Knudsen, solution–diffusion and surface transport are standard; parallel-mechanism selectivity is discussed in the membrane literature. | A constrained-parameter map showing where reversals survive measurement-based isotherms. Unassessed. |
| Response time | First-order lag and Bode response; the R ratio is the standard dimensionless frequency. | A cross-order collapse, if one exists. Likely nothing new. Unassessed. |
| Enzyme | Competitive kinetics already fixes relative rates. | Only a systematic departure would be new. Unassessed. |
| Fog | Interception and drainage models exist separately; spacing ratios are studied. | A joint collected-and-drained optimum across wettability. Unassessed. |
| Cellular | Mean-expression prediction of drug response is well developed. | Whether within-population dispersion adds information. Unassessed. |
No prior-art search has been performed for this package. Every "could be new" cell is unassessed and must not be quoted as a novelty claim. A literature check precedes any promotion of these tests.
| Source | Used for | Status |
|---|---|---|
| DepMap portal | Cellular variability: expression and drug response | Pointer only; not accessed or verified for this plan |
| Sanger DepMap | Cellular variability: second response source | Pointer only; not verified |
| SABIO-RK | Enzyme kinetics: k_cat, K_m | Pointer only; not verified |
| BRENDA | Enzyme kinetics: downloadable constants | Pointer only; licence terms not checked |
No dataset was downloaded, joined or inspected in preparing this page. No number above is a measurement.
Status: planning document, 3 November 2026. All five investigations are planned. No experiment was performed; no result, novelty or data suitability is claimed. Original hypothesis wording is preserved above each refinement. Negative and inconclusive outcomes are to be published with the same weight as supportive ones.